NCT01373086 - LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Hypertension

Interventions

DRUG

LFF269

DRUG

Eplerenone

DRUG

Placebo

Trial Locations (11)

Clinical Research Atlanta, Stockbridge

Comprehensive Phase One®,, Miramar

Comprehensive NeuroScience, St. Petersburg

Clinical Research Advantage/ Prairie Fields Family Medicine, PC, Fremont

Internal Medicine Physicians, Omaha

ICON Developmental Solutions, Omaha

ICON Development Solutions,, San Antonio

Clinical Research Advantage/ Aloha Medical, Las Vegas

Advanced Clinical Research Institute-Phase I, Anaheim

Comprehensive Clinical Development NW, Inc., Tacoma

Comprehensive Phase I, Fort Myers